Background: Severe acute colitis is a common complication of inflammatory bowel disease (IBD). Their diagnosis is based on clinical, laboratory, endoscopic and radiological. The severe acute colitis is a medical and surgical emergency; its mortality is 1% to 3%. The management should be swift and coordinated, upon admission, between medical and surgical teams. Methods: This is a retrospective study in Gastroenterology Service at the University Hospital HASSAN II Fez, over a period of 10 years (2005-2015). We included all patients admitted for severe acute colitis; all the epidemiological, clinical, endoscopic, histological, and therapeutic monitoring of patients were collected. Results: We collected 123 patients. Their average age was 35 years (16 - 70). It was a female predominance (sex ratio F/M = 1.19). 54 patients were admitted for an inaugural severe acute colitis (43%), while 69 patients were known carriers of IBD (56%). All patients were admitted to an array of severe acute colitis according to the criteria of Truelove and Witts modified. 9 patients were operated urgently because there was the presence of complications (5 cases of perforation, 3 cases of massive rectal bleeding, and one patient with an abscess in the right iliac fossa). Corticosteroids intravenously was administered to 114 patients, 74 patients (64%) had remission. Patients who have not responded to corticosteroids IV (N = 40): 1) 12 patients received treatment with oral cyclosporine: the remission rate was 66%. 2) 8 patients were put under Infliximab: The response rate was 75%. 3) Patients who have not responded to a second-line treatment underwent subtotal colectomy with a dual stoma. 4) The surgery was indicated as a second-line treatment in 20 patients who all received a subtotal colectomy with double stoma; totalizing colectomy and ileoanale anastomosis ware made in 4 patients. The mortality rate is higher in our series (12%) mainly postoperatively; it is due to the delayed admission of patients, which promotes the development of complications. Conclusion: Acute Severe Ulcerative Colitis is a medical and surgical emergency that requires a multidisciplinary approach; medical treatment is the basis of initial treatment; but surgery must always be indicated at the right time avoiding increasing the death rate, this rate is important in our series.
KeywordsAcute Severe Ulcerative ColitisInfliximabCyclosporineColectomy
Jewell, D., et al. (1991) Indications and Timing of Surgery for Severe Ulcerative Colitis. Gastroenterology International, 4, 161-164.
Dignass, A., Lindsay, J., Sturm, A., et al. (2012) Second European Evidence-Based Consensus on the Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management. Journal of Crohn’s and Colitis, 6, 991-1030. https://doi.org/10.1016/j.crohns.2012.09.002
Turner, D., Walsh, C.M., Steinhart, A.H. and Griffiths, A.M. (2007) Response to Corticosteroids in Severe Ulcerative Colitis: A Systematic Review of the Literature and Meta-Regression. Clinical Gastroenterology and Hepatology, 5, 103-110. https://doi.org/10.1016/j.cgh.2006.09.033
Travis, S.P., Farrant, J.M., Ricketts, C., et al. (1996) Predicting Outcome in Severe Ulcerative Colitis. Gut, 38, 905-910. https://doi.org/10.1136/gut.38.6.905
Carbonnel, F., Gargouri, D., Lémann, M., et al. (2000) Predictive Factors of Outcome of Intensive Intravenous Treatment for Attacks of Ulcerative Colitis. Alimentary Pharmacology and Therapeutics, 14, 273-279. https://doi.org/10.1046/j.1365-2036.2000.00705.x
Benazzato, L., D’Inca, R., Grigoletto, F., et al. (2004) Prognosis of Severe Attacks in Ulcerative Colitis: Effect of Intensive Medical Treatment. Digestive and Liver Disease, 36, 461-466. https://doi.org/10.1016/j.dld.2003.12.017
Daperno, M., Sostegni, R., Scaglione, N., et al. (2004) Outcome of a Conservative Approach in Severe Ulcerative Colitis. Digestive and Liver Disease, 36, 21-28. https://doi.org/10.1016/j.dld.2003.04.001
Manosa, M., Cabré, E., Garcia-Planella, E., et al. (2011) Decision Tree for Early Introduction of Rescue Therapy in Active Ulcerative Colitis Treated with Steroids. Inflammatory Bowel Diseases, 17, 2497-2502. https://doi.org/10.1002/ibd.21634
Gan, S.I. and Beck, P.L. (2003) A New Look at Toxic Megacolon: An Update and Review of Incidence, Etiology, Pathogenesis, and Management. American Journal of Gastroenterology, 98, 2363-2371. https://doi.org/10.1111/j.1572-0241.2003.07696.x
Dinesen, L.C., Walsh, A.J., Protic, M.N., et al. (2010) The Pattern and Outcome of Acute Severe Colitis. Journal of Crohn’s and Colitis, 4, 431-437. https://doi.org/10.1016/j.crohns.2010.02.001
Hoie, O., Wolters, F., Riss, L., Bernklev, T., Aamodt, G., Clofent, J., et al. (2007) Low Colectomy Rates in Ulcerative Colitis in an Unselected European Cohort Followed for 10 Years. Gastroenterology, 132, 507-515. https://doi.org/10.1053/j.gastro.2006.11.015
Kaplan, G.G., McCarthy, E.P., Ayanian, J.Z., Korzenik, J., Hodin, R. and Sands, B.E. (2008) Impact of Hospital Volume on Postoperative Morbidity and Mortality Following a Colectomy for Ulcerative Colitis. Gastroenterology, 134, 680-687. https://doi.org/10.1053/j.gastro.2008.01.004
Saha, S.K., Kumar, A., Panwar, R., et al. (2015) Early Colectomy in Steroid-Refractory Acute Severe Ulcerative Colitis Improves Operative Outcome. Apollo Medicine, 12, S25. https://doi.org/10.1016/j.apme.2015.11.073
Seo, H.I., Park, D.I., Kim, T.O., et al. (2014) The Effect of Infliximab on Patients with Ulcerative Colitis in Korea. Intestinal Research, 12, 214-220. https://doi.org/10.5217/ir.2014.12.3.214
Gisbert, J.P., Gonzalez-Lama, Y. and Mate, J. (2007) Systematic Review: Infliximab Therapy in Ulcerative Colitis. Alimentary Pharmacology & Therapeutics, 25, 19-37. https://doi.org/10.1111/j.1365-2036.2006.03131.x
Arias, M.T., Casteele, N.V., Vermeire, S., et al. (2015) A Panel to Predict Long-Term Outcome of Infliximab Therapy for Patients with Ulcerative Colitis. Clinical Gastroenterology and Hepatology, 13, 531-538. https://doi.org/10.1016/j.cgh.2014.07.055
Monterubbianesi, R., Aratari, A., Armuzzi, A., et al. (2014) Infliximab Three-Dose Induction Regimen in Severe Corticosteroid-Refractory Ulcerative Colitis: Early and Late Outcome and Predictors of Colectomy. Journal of Crohn’s and Colitis, 8, 852-858. https://doi.org/10.1016/j.crohns.2014.01.006
Creed, T.J. and Probert, C.S. (2007) Review Article: Steroid Resistance in Inflammatory Bowel Disease—Mechanisms and Therapeutic Strategies. Alimentary Pharmacology & Therapeutics, 25, 111-122. https://doi.org/10.1111/j.1365-2036.2006.03156.x
de Saussure, P., Soravia, C., Morel, P. and Hadengue, A. (2005) Low-Dose Oral Microemulsion Ciclosporin for Severe, Refractory Ulcerative Colitis. Alimentary Pharmacology & Therapeutics, 22, 203-208. https://doi.org/10.1111/j.1365-2036.2005.02552.x
Weber, A., Fein, F., Koch, S., Dupont-Gossart, A.C., Mantion, G., Heyd, B., et al. (2006) Treatment of Ulcerative Colitis Refractory to Steroid Therapy by Microemulsion Cyclosporine (Neoral). Inflammatory Bowel Diseases, 12, 1131-1135. https://doi.org/10.1097/01.mib.0000235096.78736.8e
Chang, K.H., Burke, J.P. and Coffey, J.C. (2013) Infliximab versus Cyclosporine as Rescue Therapy in Acute Severe Steroid-Refractory Ulcerative Colitis: A Systematic Review and Meta-Analysis. International Journal of Colorectal Disease, 28, 287-293. https://doi.org/10.1007/s00384-012-1602-8
Laharie, D., Bourreille, A., Branche, J., et al. (2012) Ciclosporin versus Infliximab in Patients with Severe Ulcerative Colitis Refractory to Intravenous Steroids: A Parallel, Open-Label Randomised Controlled Trial. The Lancet, 380, 1909-1915. https://doi.org/10.1016/S0140-6736(12)61084-8
Sjöberg, M., Walch, A., Meshkat, M., et al. (2012) Infliximab or Cyclosporine as Rescue Therapy in Hospitalized Patients with Steroid-Refractory Ulcerative Colitis: A Retrospective Observational Study. Inflammatory Bowel Diseases, 18, 212-218. https://doi.org/10.1002/ibd.21680
Croft, A., Walsh, A., Doecke, J., Cooley, R., Howlett, M. and Radford-Smith, G. (2013) Outcomes of Salvage Therapy for Steroid-Refractory Acute Severe Ulcerative Colitis: Ciclosporin vs. Infliximab. Alimentary Pharmacology & Therapeutics, 38, 294-302. https://doi.org/10.1111/apt.12375
Kim, E.H., Kim, D.H., Park, S.J., et al. (2015) Infliximab versus Cyclosporine Treatment for Severe Corticosteroid-Refractory Ulcerative Colitis: A Korean, Retrospective, Single Center Study. Gut and Liver, 9, 601-606. https://doi.org/10.5009/gnl14120
Llaó, J., Naves, J.E., Ruiz-Cerulla, A., et al. (2016) Improved Outcome of Acute Severe Ulcerative Colitis While Using Early Predictors of Corticosteroid Failure and Rescue Therapies. Digestive and Liver Disease, 48, 608-612. https://doi.org/10.1016/j.dld.2016.02.024
Clementa, V., Aratari, A., Papi, C. and Vernia, P. (2016) Short Term Colectomy Rate and Mortality for Severe Ulcerative Colitis in the Last 40 Years. Has Something Changed? Digestive and Liver Disease, 48, 371-375. https://doi.org/10.1016/j.dld.2015.12.014
Alves, A. (2003) Traitement d’une colite aiguë grave compliquant une maladie inflammatoire chronique de l’intestin. American College of Surgeons, 197, 3-9.